Standard Biotools (LAB) FCF Margin (2010 - 2026)
Standard Biotools' (LAB) quarterly FCF Margin came in at 221.87% in Q1 2026, down 4712.0% year-on-year from 4.81% in Q1 2025, and down 2669.85% on a QoQ basis from 8.01% in Q4 2025.
Standard Biotools (LAB) FCF Margin (2010 - 2026) Analysis & Trends
Standard Biotools (LAB) has 17 years of FCF Margin data on file, last reported at 221.87% in Q1 2026.
- On a quarterly basis, FCF Margin fell 4712.0% year-over-year to 221.87% in Q1 2026; TTM through Mar 2026 was 100.6%, a 3040.0% increase from a year earlier, with the FY2025 full-year figure at 88.12%, up 7150.0% from the prior year.
- FCF Margin for Q1 2026 stood at 221.87%, down from 8.01% in the prior quarter.
- Over the last five years, FCF Margin for LAB reached as high as 8.01% in Q4 2025 and fell as low as 221.87% in Q1 2026.
- Historically, FCF Margin has averaged 97.47% across 5 years, with a median of 73.78% in 2022.
- Across the five-year window, FCF Margin jumped 12795 bps in 2023 and plunged 13340 bps in 2024, its largest moves.
- Year by year, FCF Margin stood at 73.78% in 2022, then surged by 46 bps to 40.12% in 2023, then decreased by 10 bps to 43.99% in 2024, then soared by 82 bps to 8.01% in 2025, then plunged by 2670 bps to 221.87% in 2026.
- Per Business Quant data, the three most recent FCF Margin figures were 221.87% in Q1 2026, 8.01% in Q4 2025, and 113.31% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -1.28% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 37.67% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 2.18% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 6.68% |
| 10 | Standard Biotools | 299.46 Mn | -155.72 Mn | 11.31 Mn | -221.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -221.87% |
| Dec 31, 2025 | -8.01% |
| Sep 30, 2025 | -113.31% |
| Jun 30, 2025 | -72.59% |
| Mar 31, 2025 | -174.75% |
| Dec 31, 2024 | -43.99% |
| Sep 30, 2024 | -148.70% |
| Jun 30, 2024 | -170.14% |
| Mar 31, 2024 | -138.90% |
| Dec 31, 2023 | -40.12% |
| Sep 30, 2023 | -48.56% |
| Jun 30, 2023 | -36.75% |
| Mar 31, 2023 | -37.80% |
| Dec 31, 2022 | -73.78% |
| Sep 30, 2022 | -100.89% |
| Jun 30, 2022 | -164.70% |
| Mar 31, 2022 | -62.10% |
| Sep 30, 2021 | -54.01% |
| Jun 30, 2021 | -60.58% |
| Mar 31, 2021 | -60.45% |